Imaging performance in guiding response to neoadjuvant therapy according to breast cancer subtypes: A systematic literature review-Reference-Cited by-同舟云学术

Imaging performance in guiding response to neoadjuvant therapy according to breast cancer subtypes: A systematic literature review

Published:2017-04 Issue: Volume:112 Page:198-207
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Lindenberg Melanie A.,Miquel-Cases Anna,Retèl Valesca P.,Sonke Gabe S.,Wesseling Jelle,Stokkel Marcel P.M.,van Harten Wim H.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference48 articles.

1. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative;Bossuyt;Vet. Clin. Pathol.,2007

2. Accuracy of MRI for treatment response assessment after taxane- and anthracycline-based neoadjuvant chemotherapy in HER2-negative breast cancer;Charehbili;Eur. J. Surg Oncol. Engl.,2014

3. 18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis;Cheng;Acta Radiol.,2012

4. Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate;Chevallier;Am. J. Clin. Oncol.,1993

5. Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer;Chollet;Br. J. Cancer,2002

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting pathological complete response based on weakly and semi-supervised joint learning in breast cancer multi-parametric MRI;Biomedical Signal Processing and Control;2024-07

2. Cost-effectiveness of 2-[18F]FDG-PET/CT versus CE-CT for response monitoring in patients with metastatic breast cancer: a register-based comparative study;Scientific Reports;2023-09-28

3. Biopsy-Guided Pathological Response Assessment in Breast Cancer is Insufficient: Additional Pathology Findings of the MICRA Trial;Annals of Surgical Oncology;2023-04-18

4. Mammographic and Ultrasonographic Imaging Analysis for Neoadjuvant Chemotherapy Evaluation: Volume Reduction Indexes That Correlate With Pathological Complete Response;Cureus;2022-10-05

5. Machine Learning Models and Multiparametric Magnetic Resonance Imaging for the Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer;Cancers;2022-07-19